Inspire Medical Systems, Inc.
INSP· NYSE
INSPInspire Medical Systems, Inc.
Filed Feb 15, 2022 · 10-K · 46 days after period end · 0001609550-22-000014
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $78.40M | $46.01M | $26.91M | $16.56M |
| Net Income | -$2.39M | -$7.48M | -$9.08M | -$4.78M |
| EPS Diluted | — | -$0.28 | -$0.38 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 15, 2022 · 46 d after period end
